Skip to content
The GLP-1 Verdict
Menu

The alternatives

The best alternatives to VevaRX

VevaRX scores 61/100 (grade C, ranked #348) on The Verdict Score. Here are the GLP-1 providers we'd weigh against it, scored on the same six-factor rubric. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.

This shortlist uses nearby positions in our published ranking, with our featured partner shown first. It compares program terms and features; your clinician must assess treatment suitability.

Published by The GLP-1 Verdict

Pricing sources checked: latest October 2026

Check dates vary by provider.

  • VevaRX: September 2026
  • CoreAge Rx: August 2026
  • Luvo Health: October 2026
  • BeyondMD: October 2026
  • Spry: Check date not recorded
  • Eve: Check date not recorded
  • TeleHealth Med: Check date not recorded
  • Fitstry: Check date not recorded

Read our full VevaRX review →

Grade C

Luvo Health

Publishes an unusually complete price grid covering compounded injections, oral tablets and brand Ozempic and Zepbound, but charges you before any clinician has reviewed your intake.

Luvo Health scores 59/100 to VevaRX's 61; our Luvo Health review in full has the pricing conditions and the caveats in detail.

Sema
$209 per 4 weeks (injection)
Tirz
$249 per 4 weeks (injection)
Coverage
Multi-state
Grade C

BeyondMD

Telehealth clinic offering competitively priced compounded semaglutide and tirzepatide.

BeyondMD matches VevaRX at 61/100; the full BeyondMD review has the pricing conditions and the caveats in detail.

Sema
From $125/mo (starting dose, compounded)
Tirz
From $199/mo (starting dose, compounded)
Coverage
All 50 states
Grade C

Spry

Spry is a weight-loss and anti-aging telehealth platform pairing compounded semaglutide ($199/mo) and tirzepatide ($299/mo) with three longevity peptides — BPC-157, NAD+, and sermorelin ($249–$299/mo).

Spry scores 62/100 to VevaRX's 61; our full write-up on Spry has the pricing conditions and the caveats in detail.

Sema
From $199/mo (starting dose, compounded)
Tirz
From $299/mo (starting dose, compounded)
Coverage
Not disclosed
Grade C

Eve

Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual…

Eve matches VevaRX at 61/100; our full write-up on Eve has the pricing conditions and the caveats in detail.

Sema
From $195/mo (compounded)
Tirz
From $195/mo (compounded)
Coverage
Not disclosed
Grade C

TeleHealth Med

TeleHealth Med (TeleHealth Med, Inc.) is a Georgia-based telehealth weight-loss platform offering compounded semaglutide and tirzepatide in both injectable and sublingual forms through US-licensed…

TeleHealth Med scores 62/100 to VevaRX's 61; the full TeleHealth Med review has the pricing conditions and the caveats in detail.

Sema
From $147/mo (starting dose, compounded)
Tirz
Not disclosed
Coverage
Not disclosed
Grade C

Fitstry

Fitstry is the GLP-1 weight-loss program of Weightstry, LLC, a LegitScript-certified, cash-pay telehealth practice focused on women 40+.

Fitstry matches VevaRX at 61/100; our Fitstry review in full has the pricing conditions and the caveats in detail.

Sema
From $179/mo (12-mo plan, plus a separate fee, compounded)
Tirz
From $269/mo (12-mo plan, compounded)
Coverage
Not disclosed

See the complete rankings, the alternatives to every provider, A to Z, or head to the comparison hub.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.